Beurs.nl monitor iconMarkt Monitor
  • AEX -7,22 907,46 -0,79%
  • DE40 0,00 22.678,74 0,00%
  • US500^ -111,06 5.582,52 -1,95%
  • US30^ -711,10 41.603,40 -1,68%
  • EUR/USD +0,00 1,0826 +0,27%
  • WTI -0,75 69,19 -1,07%
  • Gold spot +25,12 3.080,12 +0,82%

MDxHealth news 2012

467 Posts
Pagina: 1 2 3 4 5 6 ... 24 »» | Laatste | Omlaag ↓
  1. Nel 7 februari 2012 08:50
    MDxHealth Receives 2011 European Molecular Diagnostics for Oncology Technology Leadership Award january 9 2012

    MDxHealth Receives CLIA Certification and California State License for its Clinical Laboratory 23 january 2012

    finance.yahoo.com/news/Time-Exact-Sci...
    verplaatst naar nabeurstijd!wellicht news from exact . 7 feb 2012

    dit draadtje is voor de komende mnd waar nieuwe berichtgeving wordt verwacht.

    February 21-23, 2012

    MDxHealth to Present at Molecular MedTRI-CON 2012

    www.triconference.com/mdx

  2. Nel 7 februari 2012 11:34
    2012 Newsflow

    H1 – Publication Prostate biopsy tissue minimization Study
    H1 - New companion diagnostic deal with pharma
    H1 – First Prostate service testing offered
    H1 – Presenting data from US prostate cancer trial
    H1- Publishing results of Health economic study
    H2 – CE marking of MGMT assay
    H2 - Expected first revenue from Prostate ConfirmMDx
    H2 – Submission of Exact Sciences colorectal cancer data to the FDA
    H2 – Publication of Prostate Cancer studies
    H2 – Publication Lung ConfirmMDx data
    H2 – Additional Laboratory State Licensees

    genoeg teverwachten
  3. Nel 7 februari 2012 23:23
    Exact meldt vandaag : The EU market is 1.5 billion per year
  4. Nel 8 februari 2012 14:56
    Take aways on UBS conference. 8-Feb-12 07:18 am

    New stuff...

    Finally, a worldwide perspective. KC mentioned India & China as future markets, but did not indicate any specifics. Also, on the automation front...he expects automation to be ready by the time all of the samples are collected (September of this year?) $3B between US (30% mkt penetration) and EU (10% mkt penetration). EU ranks highest in incidence and mortality of crc. 63.8 million shares fully diluted.
  5. Nel 21 februari 2012 10:33
    quote:

    NEL schreef op 7 februari 2012 11:34:

    2012 Newsflow

    H1 – Publication Prostate biopsy tissue minimization Study
    H1 - New companion diagnostic deal with pharma
    H1 – First Prostate service testing offered
    H1 – Presenting data from US prostate cancer trial
    H1- Publishing results of Health economic study
    H2 – CE marking of MGMT assay
    H2 - Expected first revenue from Prostate ConfirmMDx
    H2 – Submission of Exact Sciences colorectal cancer data to the FDA
    H2 – Publication of Prostate Cancer studies
    H2 – Publication Lung ConfirmMDx data
    H2 – Additional Laboratory State Licensees

    genoeg teverwachten
    Publication Prostate biopsy tissue minimization Study
    vandaag of morgen!!
  6. Nel 21 februari 2012 13:58
    als de koers spoedig boven de 2+ noteert hahahahaha

    vandaag!!zou voorkennis zijn alvorens :

    February 21-23, 2012

    MDxHealth to Present at Molecular MedTRI-CON 2012

    www.triconference.com/mdx

    begint.

    nabeurs of morgen wellicht news vanuit MDx kamp

  7. Nel 21 februari 2012 14:34
    newsflow 2012 zegt voldoende.

    bedrijf gaat na jaren eindelijk zich opmaken naar een cashflow bedrijf.

    succes
  8. Nel 23 februari 2012 08:49
    March 21-22, 2012

    MDxHealth To Present at Kempen & Co Healthcare/Life Sciences Conference

  9. Nel 23 februari 2012 13:31
    •Q4 2011 Exact Sciences Corp Earnings Release - Before Market OpenCCBN(Thu 7:07AM EST)
  10. Nel 23 februari 2012 13:56
    “We are pleased that the DeeP-C clinical trial for our Cologuard®product, a noninvasive colorectal cancer screening test, remains on track,” said Kevin T. Conroy, president and chief executive of Exact. “During 2012, our priorities are completing the DeeP-C trial, making our FDA submission, and continuing our manufacturing and marketing preparation. All of us at Exact are focused on bringing to market our patient-friendly screening test, which enables early detection of colorectal cancer.”
467 Posts
Pagina: 1 2 3 4 5 6 ... 24 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.119
AB InBev 2 5.538
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.173
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.857
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.839
Aedifica 3 926
Aegon 3.258 323.075
AFC Ajax 538 7.089
Affimed NV 2 6.305
ageas 5.844 109.905
Agfa-Gevaert 14 2.063
Ahold 3.538 74.353
Air France - KLM 1.025 35.290
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.050
Alfen 16 25.276
Allfunds Group 4 1.517
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 420
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.901
AMG 971 134.353
AMS 3 73
Amsterdam Commodities 305 6.745
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 496
Antonov 22.632 153.605
Aperam 92 15.056
Apollo Alternative Assets 1 17
Apple 5 386
Arcadis 252 8.806
Arcelor Mittal 2.034 320.983
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.352
Aroundtown SA 1 221
Arrowhead Research 5 9.751
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.614
ASML 1.766 110.151
ASR Nederland 21 4.512
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.937
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.449